Ocata Therapeutics Inc fka OCAT

[art2426]

I agree. With a HEDGEFUND manager as CEO, we will never be looked at as a bonafide legimate profit making entity. He is not and never will be a "business mind". Wall street will take this into consideration when evaluating the potential financial prosperity of this company and our stock price will reflect that as I believe it does now. Rabin MUST be replaced if and when these trials are successful. Throw in his unreporting of stock sales and you have every reason to question the personal agenda of this CEO - Is he working for his shareholders or for his own solely, self centered financial wealth, AT THE EXPENSE OF HIS SHAREHOLDERS.